1. American Diabetes Association (2019) Cardiovascular disease and risk management: Standards of medical care in diabetes-2019. Diabetes Care 42:S103–S123. https://doi.org/10.2337/dc19S010
2. American Diabetes Association (2019) Microvascular complications and foot care: Standards of medical care in diabetes-2019. Diabetes Care 42:S124–S138. https://doi.org/10.2337/dc19-s011
3. Bertheim U, Engström-Laurent A, Hofer PÅ, et al (2002) Loss of hyaluronan in the basement membrane zone of the skin correlates to the degree of stiff hands in diabetic patients. Acta Derm Venereol 82:329–334. https://doi.org/10.1080/000155502320624041
4. Brown SJ, McLean WHI (2012) One remarkable molecule: Filaggrin. J Invest Dermatol 132:751–762. https://doi.org/10.1038/jid.2011.393
5. Cai SCS, Chen H, Koh WP, et al (2012) Filaggrin mutations are associated with recurrent skin infection in Singaporean Chinese patients with atopic dermatitis. Br J Dermatol 166:200–203. https://doi.org/10.1111/j.1365-2133.2011.10541.x
6. Candi E, Schmidt R, Melino G (2005) The cornified envelope: A model of cell death in the skin. Nat Rev Mol Cell Biol 6:328–340. https://doi.org/10.1038/nrm1619
7. Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper EF (2009) The use of animal models in the study of diabetes mellitus. In Vivo (Brooklyn) 23:245–258
8. Chen X fang, Lin W dong, Lu S liang, et al (2010) Mechanistic study of endogenous skin lesions in diabetic rats. Exp Dermatol 19:1088–1095. https://doi.org/10.1111/j.1600-0625.2010.01137.x
9. Dash BC, Xu Z, Lin L, et al (2018) Stem cells and engineered scaffolds for regenerative wound healing. Bioengineering 5:1–19. https://doi.org/10.3390/bioengineering5010023
10. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736–1743. https://doi.org/10.1016/S0140-6736(05)67700-8
11. Ferringer T, MillerIII F (2002) Cutaneous manifestations of diabetes mellitus. Dermatol Clin 20:483–492. https://doi.org/10.1016/s0733-8635(02)00018-9
12. Li C, Hou S, Liu S, et al (2017) The albumin-exendin-4 recombinant protein E2HSA improves glycemic control and β-cell function in spontaneous diabetic KKAy mice. BMC Pharmacol Toxicol 18:1–9. https://doi.org/10.1186/s40360-017-0143-8
13. Lima AL, Illing T, Schliemann S, Elsner P (2017) Cutaneous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol 18:541–553. https://doi.org/10.1007/s40257-017-0275-z
14. Muller LMAJ, Gorter KJ, Hak E, et al (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41:281–288.
https://doi.org/10.1086/431587
15. Okano J, Kojima H, Katagi M, et al (2016) Hyperglycemia induces skin barrier dysfunctions with impairment of epidermal integrity in non-wounded skin of type 1 diabetic mice. PLoS One 11:1–22. https://doi.org/10.1371/journal.pone.0166215
16. Park HY, Kim JH, Jung M, et al (2011) A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol 20:969–974. https://doi.org/10.1111/j.1600-0625.2011.01364.x
17. Rodgers KE, Ellefson DD, Espinoza T, et al (2006) Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury. Wound Repair Regen 14:298–305. https://doi.org/10.1111/j.1743-6109.2006.00124.x
18. Sakai S, Endo Y, Ozawa N, et al (2003) Characteristics of the epidermis and stratum corneum of hairless mice with experimentally induced diabetes mellitus. J Invest Dermatol 120:79–85. https://doi.org/10.1046/j.1523-1747.2003.12006.x
19. Sandilands A, Sutherland C, Irvine AD, McLean WHI (2009) Filaggrin in the frontline: Role in skin barrier function and disease. J Cell Sci 122:1285–1294. https://doi.org/10.1242/jcs.033969
20. Taylor KR, Costanzo AE, Jameson JM (2011) Dysfunctional γδ T Cells Contribute to Impaired Keratinocyte Homeostasis in Mouse Models of Obesity. J Invest Dermatol 131:2409–18. https://doi.org/10.1038/jid.2011.241
21. Yoneda K, Nakagawa T, Lawrence OT, et al (2012) Interaction of the profilaggrin N-terminal domain with loricrin in human cultured keratinocytes and epidermis. J Invest Dermatol 132:1206–1214. https://doi.org/10.1038/jid.2011.460